Cargando…

A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil

Right-sided heart failure—often caused by elevated pulmonary arterial pressure—is a chronic and progressive condition with particularly high mortality rates. Recent studies and our current findings suggest that components of Wild garlic (Allium ursinum, AU) may play a role in reducing blood pressure...

Descripción completa

Detalles Bibliográficos
Autores principales: Bombicz, Mariann, Priksz, Daniel, Varga, Balazs, Kurucz, Andrea, Kertész, Attila, Takacs, Akos, Posa, Aniko, Kiss, Rita, Szilvassy, Zoltan, Juhasz, Bela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535927/
https://www.ncbi.nlm.nih.gov/pubmed/28677661
http://dx.doi.org/10.3390/ijms18071436
_version_ 1783253926491979776
author Bombicz, Mariann
Priksz, Daniel
Varga, Balazs
Kurucz, Andrea
Kertész, Attila
Takacs, Akos
Posa, Aniko
Kiss, Rita
Szilvassy, Zoltan
Juhasz, Bela
author_facet Bombicz, Mariann
Priksz, Daniel
Varga, Balazs
Kurucz, Andrea
Kertész, Attila
Takacs, Akos
Posa, Aniko
Kiss, Rita
Szilvassy, Zoltan
Juhasz, Bela
author_sort Bombicz, Mariann
collection PubMed
description Right-sided heart failure—often caused by elevated pulmonary arterial pressure—is a chronic and progressive condition with particularly high mortality rates. Recent studies and our current findings suggest that components of Wild garlic (Allium ursinum, AU) may play a role in reducing blood pressure, inhibiting angiotensin-converting enzyme (ACE), as well as improving right ventricle function in rabbit models with heart failure. We hypothesize that AU may mitigate cardiovascular damage caused by pulmonary arterial hypertension (PAH) and has value in the supplementary treatment of the complications of the disease. In this present investigation, PAH was induced by a single dose of monocrotaline (MCT) injection in Sprague-Dawley rats, and animals were divided into 4 treatment groups as follows: I. healthy control animals (Control group); II. pulmonary hypertensive rats (PAH group); III. pulmonary hypertensive rats + daily sildenafil treatment (Sildenafil group); and IV. pulmonary hypertensive rats + Wild garlic liophylisate-enriched chow (WGLL group), for 8 weeks. Echocardiographic measurements were obtained on the 0 and 8 weeks with fundamental and Doppler imaging. Isolated working heart method was used to determinate cardiac functions ex vivo after thoracotomy on the 8th week. Histological analyses were carried out on excised lung samples, and Western blot technique was used to determine Phosphodiesterase type 5 enzyme (PDE5) expression in both myocardial and pulmonary tissues. Our data demonstrate that right ventricle function measured by echocardiography was deteriorated in PAH animals compared to controls, which was counteracted by AU treatment. Isolated working heart measurements showed elevated aortic flow in WGLL group compared to PAH animals. Histological analysis revealed dramatic increase in medial wall thickness of pulmonary arteries harvested from PAH animals, but arteries of animals in sildenafil- and WGLL-treated groups showed physiological status. Our results suggest that bioactive compounds in Allium ursinum could have beneficial effects in pulmonary hypertension.
format Online
Article
Text
id pubmed-5535927
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-55359272017-08-04 A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil Bombicz, Mariann Priksz, Daniel Varga, Balazs Kurucz, Andrea Kertész, Attila Takacs, Akos Posa, Aniko Kiss, Rita Szilvassy, Zoltan Juhasz, Bela Int J Mol Sci Article Right-sided heart failure—often caused by elevated pulmonary arterial pressure—is a chronic and progressive condition with particularly high mortality rates. Recent studies and our current findings suggest that components of Wild garlic (Allium ursinum, AU) may play a role in reducing blood pressure, inhibiting angiotensin-converting enzyme (ACE), as well as improving right ventricle function in rabbit models with heart failure. We hypothesize that AU may mitigate cardiovascular damage caused by pulmonary arterial hypertension (PAH) and has value in the supplementary treatment of the complications of the disease. In this present investigation, PAH was induced by a single dose of monocrotaline (MCT) injection in Sprague-Dawley rats, and animals were divided into 4 treatment groups as follows: I. healthy control animals (Control group); II. pulmonary hypertensive rats (PAH group); III. pulmonary hypertensive rats + daily sildenafil treatment (Sildenafil group); and IV. pulmonary hypertensive rats + Wild garlic liophylisate-enriched chow (WGLL group), for 8 weeks. Echocardiographic measurements were obtained on the 0 and 8 weeks with fundamental and Doppler imaging. Isolated working heart method was used to determinate cardiac functions ex vivo after thoracotomy on the 8th week. Histological analyses were carried out on excised lung samples, and Western blot technique was used to determine Phosphodiesterase type 5 enzyme (PDE5) expression in both myocardial and pulmonary tissues. Our data demonstrate that right ventricle function measured by echocardiography was deteriorated in PAH animals compared to controls, which was counteracted by AU treatment. Isolated working heart measurements showed elevated aortic flow in WGLL group compared to PAH animals. Histological analysis revealed dramatic increase in medial wall thickness of pulmonary arteries harvested from PAH animals, but arteries of animals in sildenafil- and WGLL-treated groups showed physiological status. Our results suggest that bioactive compounds in Allium ursinum could have beneficial effects in pulmonary hypertension. MDPI 2017-07-04 /pmc/articles/PMC5535927/ /pubmed/28677661 http://dx.doi.org/10.3390/ijms18071436 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bombicz, Mariann
Priksz, Daniel
Varga, Balazs
Kurucz, Andrea
Kertész, Attila
Takacs, Akos
Posa, Aniko
Kiss, Rita
Szilvassy, Zoltan
Juhasz, Bela
A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil
title A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil
title_full A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil
title_fullStr A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil
title_full_unstemmed A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil
title_short A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil
title_sort novel therapeutic approach in the treatment of pulmonary arterial hypertension: allium ursinum liophylisate alleviates symptoms comparably to sildenafil
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535927/
https://www.ncbi.nlm.nih.gov/pubmed/28677661
http://dx.doi.org/10.3390/ijms18071436
work_keys_str_mv AT bombiczmariann anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT prikszdaniel anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT vargabalazs anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT kuruczandrea anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT kerteszattila anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT takacsakos anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT posaaniko anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT kissrita anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT szilvassyzoltan anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT juhaszbela anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT bombiczmariann noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT prikszdaniel noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT vargabalazs noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT kuruczandrea noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT kerteszattila noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT takacsakos noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT posaaniko noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT kissrita noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT szilvassyzoltan noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil
AT juhaszbela noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil